Metformin XR – possible causes of intolerance

Czech version

Authors: Zbynek Schroner
Authors‘ workplace: Lekárska fakulta, Univerzita Pavla Jozefa Šafárika v Košiciach
Published in: Diab Obez 2025; 25(1): 51
Category: News

Sources

Jiří Zeman, Jakub Vysloužil, Jan Elbl, Sylvie Pavloková DMEV 2024; 27(3): 145–151.

Labels

Diabetology Obesitology

Editoriál

Experience with the management of patients with extreme obesity – Part 2

Tirzepatide – a dual incretin agonist in the management of type 2 diabetes mellitus: a review of evidence from the SURPASS trials

Efficacy and safety of canagliflozin – a brief overview of the results of relevant clinical studies (meta-analyses and network analyses)

Physical activity with a hybrid closed-loop system

The addictive potential and the neurobiological mechanisms underlying the consumption of hyperpalatable foods: Does food addiction exist?

Mild autonomous cortisol secretion from a diabetologist's point of view

How should we proceed today with primary prevention of cardiovascular disease – data affects women

Patients with T2DM without present CVD but with already present risk CV-factors: case reports

20 years of the Diabetology Education Center in Martin

7th National SDS Symposium: Where are we moving with technology in diabetes in Slovakia

Interdisciplinary Dialogue on the Treatment of Cardio-metabolic Syndrome (31 January – 1 February 2025, Bratislava): report

Advanced Technologies & Treatments for Diabetes, Amsterdam, 19–22 March 2025

MUDr. Michaela Važanová – portrét ambulantnej diabetologičky

MUDr. Viliam Vaník – portrét ambulantného diabetóga

Article was published in

Diabetes and obesity

2025 Issue 1